{
    "2018-05-15": [
        [
            {
                "time": "2018-05-15",
                "original_text": "乐普医疗事件点评：Q1业绩快速增长 Q2增速有望提升",
                "features": {
                    "keywords": [
                        "乐普医疗",
                        "Q1业绩",
                        "快速增长",
                        "Q2增速",
                        "有望提升"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-15",
                "original_text": "澳保健品商S66药业IPO获超额认购明日上市 ASX再添新锐",
                "features": {
                    "keywords": [
                        "S66药业",
                        "IPO",
                        "超额认购",
                        "明日上市",
                        "ASX"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "保健"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-05-15",
                "original_text": "看好中国｜健康中国——特朗普医改对国内影响有限",
                "features": {
                    "keywords": [
                        "健康中国",
                        "特朗普医改",
                        "国内影响",
                        "有限"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-05-15",
                "original_text": "[超评级]医药保健行业重大事件快评：特朗普医改：对国内影响有限 更关注中美药价倒挂的冲击",
                "features": {
                    "keywords": [
                        "特朗普医改",
                        "国内影响",
                        "中美药价倒挂",
                        "冲击"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-05-15",
                "original_text": "医药行业卓越推：华兰生物(002007)",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "卓越推"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-15",
                "original_text": "【医药*全铭团队】医药指数年初至今涨幅10.2%，“去芜存菁，慢牛行情”刚起步，此时医药更具备投资价值",
                "features": {
                    "keywords": [
                        "医药指数",
                        "涨幅",
                        "慢牛行情",
                        "投资价值"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-15",
                "original_text": "医药生物行业17年报18年一季报总结:增速回升,内部分化,关注创新、优质仿制药、连锁药店、医药商业",
                "features": {
                    "keywords": [
                        "医药生物",
                        "增速回升",
                        "内部分化",
                        "创新",
                        "仿制药",
                        "连锁药店",
                        "医药商业"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}